Education
About Us
Working with TipRanks
Follow Us
Aceso Life Science Group Limited (HK:0474)
:0474
RESEARCH TOOLSreports
Total Valuation
Aceso Life Science Group Limited has a market cap or net worth of HK$280.51M. The enterprise value is HK$3.16B.
Market CapHK$280.51M
Enterprise ValueHK$3.16B
Share Statistics
Aceso Life Science Group Limited has 7,381,777,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding7,381,777,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Aceso Life Science Group Limited’s return on equity (ROE) is -74.58 and return on invested capital (ROIC) is -0.78%.
Return on Equity (ROE)-74.58
Return on Assets (ROA)-0.28
Return on Invested Capital (ROIC)-0.78%
Return on Capital Employed (ROCE)-0.02
Revenue Per Employee1.34M
Profits Per Employee-7.03M
Employee Count146
Asset Turnover0.06
Inventory Turnover52.50
Valuation Ratios
The current PE Ratio of Aceso Life Science Group Limited is ―. Aceso Life Science Group Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio―
PB Ratio―
Price to Fair Value30.59
Price to FCF―
Price to Operating Cash Flow-1.87
PEG Ratio―
Income Statement
In the last 12 months, Aceso Life Science Group Limited had revenue of 195.00M and earned -895.00M in profits. Earnings per share was -0.12.
Revenue195.00M
Gross Profit90.00M
Operating Income-24.00M
Pretax Income-1.03B
Net Income-895.00M
EBITDA-860.00M
Earnings Per Share (EPS)-0.12
Cash Flow
In the last 12 months, operating cash flow was -73.00M and capital expenditures 0.00, giving a free cash flow of -80.00M billion.
Operating Cash Flow-73.00M
Free Cash Flow-80.00M
Free Cash Flow per Share-0.01
Dividends & Yields
Aceso Life Science Group Limited pays an annual dividend of HK$0.06, resulting in a dividend yield of ―
Dividend Per ShareHK$0.06
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.52
52-Week Price Change-50.00%
50-Day Moving Average0.02
200-Day Moving Average0.03
Relative Strength Index (RSI)62.09
Average Volume (3m)21.22M
Important Dates
Aceso Life Science Group Limited upcoming earnings date is Dec 2, 2025, TBA (Confirmed).
Last Earnings DateJun 27, 2025
Next Earnings DateDec 2, 2025
Ex-Dividend DateAug 14, 2009
Financial Position
Aceso Life Science Group Limited as a current ratio of 0.28, with Debt / Equity ratio of 19175.00%
Current Ratio0.28
Quick Ratio0.28
Debt to Market Cap6.20
Net Debt to EBITDA-2.52
Interest Coverage Ratio-0.19
Taxes
In the past 12 months, Aceso Life Science Group Limited has paid -10.00M in taxes.
Income Tax-10.00M
Effective Tax Rate<0.01
Enterprise Valuation
Aceso Life Science Group Limited EV to EBITDA ratio is -2.95, with an EV/FCF ratio of 169.07.
EV to Sales13.01
EV to EBITDA-2.95
EV to Free Cash Flow169.07
EV to Operating Cash Flow149.18
Balance Sheet
Aceso Life Science Group Limited has HK$298.00M in cash and marketable securities with HK$558.00M in debt, giving a net cash position of -HK$260.00M billion.
Cash & Marketable SecuritiesHK$298.00M
Total DebtHK$558.00M
Net Cash-HK$260.00M
Net Cash Per Share-HK$0.04
Tangible Book Value Per ShareHK$0.05
Margins
Gross margin is 46.15%, with operating margin of -12.31%, and net profit margin of -458.97%.
Gross Margin46.15%
Operating Margin-12.31%
Pretax Margin-526.67%
Net Profit Margin-458.97%
EBITDA Margin-441.03%
EBIT Margin-463.08%
Analyst Forecast
The average price target for Aceso Life Science Group Limited is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast-21.03%
EPS Growth Forecast-97.01%